Delivery Order SPE2DB20D3111-SPE2DB25FA9UD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Clarithromycin 500 mg tablets in 60-count packaging, with a contract ceiling value of $1,991.72. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Clarithromycin 500 mg tablets in quantities of 60 units, with a contract ceiling value of $2,393.25. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $5,427.91 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Clarithromycin 500 mg tablets (60-count units). This is a firm fixed price contract with an ultimate completion date of June 23, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Clarithromycin 500 mg tablets (60-count units) under a firm fixed price contract. The award, issued on September 3, 2025, carries a ceiling value of $1,219.55 and is set to be completed by September 4, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,590.72 to AmerisourceBergen Drug Corp for the supply of Clarithromycin 500 mg tablets (60-count) on September 17, 2025, with completion scheduled for September 18, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clarithromycin 250 mg tablets (60-count packaging) with a ceiling value of $1,927.60 and an ultimate completion date of September 3, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $19,268.28 to AmerisourceBergen Drug Corp for the supply of Clarithromycin 500 mg tablets (60-count units). This contract, executed on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Clarithromycin 250 mg tablets in quantities of 60 units, with a ceiling value of $2,615.44. This delivery order, which is not set-aside and carries a firm fixed price, represents a competitively awarded contract with an ultimate completion date of August 15, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a $5.2K delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Clarithromycin 250 mg tablets (60-count units). This non-set-aside, competitively awarded contract employs firm fixed pricing and has an ultimate completion date of September 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 27, 2025, by the Medical Supply Chain division of the Defense Logistics Agency to supply Clarithromycin ER 500 mg tablets in a 60-count configuration. This firm fixed-price delivery order, valued at $2,362.78, represents a non-set-aside competitive award with an ultimate completion date of June 30, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9UDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clarithromycin 500 mg tablets (60-count units) under a firm fixed-price contract on September 25, 2025, with a ceiling value of $1,229.36 and a completion date of September 26, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The DLA Troop Support Medical program leverages such vendor relationships to ensure consistent pharmaceutical availability for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/25/25 |